Parallel Health World News Logo
update

Parallel Health World

cropper
update
  • Home
  • Categories
    • EcoHealth Trends
    • Healing Naturally
    • Age-Defying Diets
    • Supplement Savvy
    • Mind-Body Synergy
    • Finance and Health
    • Biolimitless
    • Tech Hacks
    • Health & Medicine
    • Political
    • BioBuzz
    • Holistic Rehabilitation Techniques
    • Practitioner Insights
    • AI In Healthcare
  • Featured Business Profiles
June 03.2026
2 Minutes Read

AI in Healthcare: Is Deskilling a Growing Concern for Clinicians?

Healthcare professionals walking through hospital, AI healthcare impact on clinical skills

Understanding AI's Impact on Health Professionals

The rapid integration of Artificial Intelligence (AI) into healthcare is revolutionizing patient care, but it brings significant challenges for medical professionals. Reports indicate that nearly three-quarters of clinicians are concerned that relying on AI could lead to a critical erosion of their decision-making skills, as found in a survey by Wolters Kluwer Health. This highlights a stark reality: while AI can improve efficiency, the risk of deskilling remains a critical issue.

Widespread AI Adoption and Deskilling Risks

Recent findings reveal that about 70% of nurses and 74% of doctors use AI tools weekly, marking a significant increase from previous years. This increased exposure reflects an ongoing trend where AI has moved beyond experimental use to becoming a daily fixture in clinical practice. Yet, the fear that repeated delegation of clinical decision-making to AI could diminish essential clinical skills has sparked concerns among healthcare providers.

The Dangers of Deskilling

Deskilling, often characterized as the erosion of critical clinical competencies due to over-reliance on technology, poses profound challenges. The risks identified in healthcare encompass not only diminishing technical skills but also a potential decline in moral judgment and empathetic patient interactions. Clinicians express fears that, as they become accustomed to AI recommendations, their cognitive engagement in diagnosis and patient care could significantly fade, making them less autonomous and more dependent on technology.

Automation Bias and Healthcare

Another significant concern is automation bias—the tendency of professionals to trust AI outputs without critical evaluation. Similar trends have emerged in sectors like aviation, where pilots have experienced accidents because they placed undue faith in automated systems. In healthcare, clinicians must remain vigilant, continuously engaging in critical questioning about AI suggestions to protect against complacency.

Training Adaptations for the Future

To combat deskilling, experts advocate for ongoing training that encourages clinicians to utilize AI as an assistive tool rather than a crutch. This includes training programs focused on critical thinking, independent diagnosis, and continued skill practice without AI assistance. This balanced approach can help maintain essential skills and ensure that healthcare professionals remain competent, resilient, and capable of delivering exceptional care.

Potential Opportunities

While concerns about deskilling are valid, AI also presents significant opportunities for improving clinical training. AI tools can provide personalized education, adaptive learning opportunities, and immediate feedback, particularly in fields like radiology. This means that when leveraged correctly, AI can enhance learning and skill development among medical trainees.

Conclusion: Finding Balance in AI Adoption

The integration of AI in healthcare signifies a transformative yet complex evolution within the profession. Striking a balance between utilizing technology to enhance efficiency while preserving the invaluable human touch is crucial. The real challenge lies not only in adopting AI but in ensuring that healthcare professionals remain equipped with the essential skills, empathy, and clinical judgment necessary to provide optimal patient care. As the medical landscape evolves, ongoing discussions about best practices will be vital in preserving the sanctity of clinical expertise.

Finance and Health

0 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts
06.03.2026

Eli Lilly's Data Sharing Ultimatum Raises 340B Drug Access Concerns

Update Eli Lilly’s Data Sharing Ultimatum: A Struggle for 340B Integrity Eli Lilly has recently announced a stern ultimatum to hospitals and medical groups participating in the 340B drug discount program, stating they must comply with new data-sharing requirements by the upcoming Monday or risk losing discounts on necessary medications. This move has ignited significant controversy within the healthcare community, highlighting the ongoing clash between pharmaceutical companies and hospitals over the proper functioning of the 340B program. The 340B Program: Overview and Context The 340B drug discount program was established to allow eligible healthcare providers, particularly those serving low-income patients, to purchase drugs at significantly reduced prices. Engaging in this program is essential for many healthcare organizations that depend on these discounts to provide affordable care. However, as the program has expanded, concerns have arisen regarding possible misuse or “double-dipping” where hospitals might receive discounts from both 340B and Medicaid. Eli Lilly's requirement for hospitals to submit claims data aims to ensure transparency and integrity within the program. Hospital Resistance and the Industry Backlash Despite over 70% compliance from hospitals, Eli Lilly's hardline stance has faced fierce opposition. Hospital associations, including the American Hospital Association, argue the data-sharing requirement constitutes an unlawful maneuver that disproportionately burdens already struggling facilities. They contend that sharing such data, while ostensibly aimed at preventing fraud, could instead heighten the likelihood of other drugmakers following suit with similar stringent demands, further jeopardizing hospital funding for low-income patients. The Broader Implications for Patients and Providers This ultimatum from Eli Lilly raises critical questions about the future of the 340B program. As Lilly emphasizes it is crucial to rooting out fraud, hospitals warn that this could lead to increased costs for patients and a potential dismantling of a program designed to assist underserved populations. If drugmakers can impose strong data-sharing policies, the implications could ripple across the healthcare landscape, complicating drug affordability for numerous healthcare providers who operate on thin financial margins. Next Steps and Call for Regulatory Intervention As healthcare organizations rally for intervention from lawmakers to assess the legality of Lilly's actions, the divide between pharmaceutical companies and healthcare providers intensifies. This standoff serves as a stark reminder of the balancing act required to protect vulnerable patient populations while maintaining the integrity of drug pricing programs like 340B. In light of these developments, it’s crucial for consumers, especially those reliant on affordable medications, to stay informed on how potential policy changes may affect their access to drugs. Engaging with local representatives to voice concerns about upcoming changes in healthcare policies could prove essential in preserving the spirit of programs designed to support patients in need.

06.03.2026

Will Ascension’s Acquisition of AmSurg Redefine Outpatient Care Access?

Update FTC Approval Paves the Way for Ascension's $3.9B AmSurg Deal The recent announcement from the Federal Trade Commission (FTC) that it will allow Ascension to proceed with its acquisition of AmSurg, contingent on the divestiture of seven ambulatory surgery centers (ASCs), has pivotal implications for patients seeking affordable outpatient care. The FTC's stipulations serve to prevent potential monopolistic scenarios that could arise from Ascension’s expansion into markets where both companies overlap, thus maintaining competitive pricing and service quality for consumers. The Need for Competitive Markets in Healthcare Healthcare systems across America have been navigating unrelenting financial pressures, with many experiencing operational losses compounded by increased demand for outpatient services. Ascension's commitment to the outpatient sector through this merger reflects a broader trend aiming to adapt to an evolving healthcare landscape that prioritizes convenience and affordability. The FTC's requirement of divestitures acts as both a safeguard for competition and a way to reassure consumers that their access to affordable surgical services remains intact. Outpatient Services: A Growing Demand Ascension's acquisition of AmSurg will add over 250 ASCs to its portfolio, bringing its total to more than 300 facilities across 35 states. This is significant given the shift in patient preference towards outpatient surgical options, a reality that has intensified in light of recent healthcare trends. “The ambulatory space has a 10%-plus CAGR going forward,” stated Ascension’s new CEO, Eduardo Conrado, highlighting the growth potential in this segment as consumers increasingly seek efficient and cost-effective surgical care. The Importance of Consumer Input The proposed order allows for a 30-day public comment period, providing consumers an opportunity to voice their thoughts on the deal. This inclusion of public feedback reflects a growing recognition of consumer power in shaping healthcare policies and ensuring that their voices are heard in decisions impacting access and affordability. Ensuring Compliance and Future Impacts Under the consent order, Ascension will be required to maintain operations at the divested facilities until the sale is completed and will have to notify the FTC about any future acquisitions of ASCs in the specified metro areas for the next decade. This level of oversight is crucial for preventing potential exploitation of markets by newly combined entities. As healthcare systems continue to align themselves with outpatient care trends, the FTC’s action not only facilitates Ascension’s strategic vision but also reinforces the importance of competition in the healthcare landscape. As consumers, remaining informed and engaged in these developments can lead to better healthcare outcomes and pricing models.

06.02.2026

Financial Integration in EHR: The Key to Future Success in Healthcare

Update Shifting the Focus: Financial Success in Healthcare For decades, Electronic Health Records (EHR) have primarily served as digital replacements for paper charts, facilitating access to clinical notes. However, as healthcare evolves, so too does the role of EHR systems. As Ash Forsyth of ModMed explains, the next era of EHR success hinges on integrating financial operations into these platforms. Providers looking to stay competitive must recognize that the landscape has shifted from mere data management to comprehensive financial management that could enhance practice viability. The End of Reliance on Manual Processes According to Forsyth, many practices still rely on outdated paper files. These conventional methods not only drain resources but also hinder practice efficiency. Transitioning to an EHR solution isn’t just about keeping up with technology; it is essential for survival in an increasingly complex regulatory and financial climate. By digitizing data, practices can automate administrative tasks and streamline financial workflows, significantly alleviating the burdens of manual reconciliation procedures prevalent in legacy systems. Embedded Finance: A Game-Changer in Healthcare Technology Incorporating embedded finance technology into EHR systems represents a substantial leap forward for healthcare platforms. By embedding payment processes directly within healthcare workflows, firms like ModMed are not just offering a financial tool but creating an integrated ecosystem that enhances the speed and reliability of reimbursements. This strategic shift can minimize inefficiencies such as long accounts receivable cycles, allowing for more predictable cash flow—an essential factor for sustaining healthcare practices. Compliance: The Competitive Edge Healthcare compliance, governed by regulations such as HIPAA, can often pose significant barriers to innovation. As Mariëtte Swart of Adyen notes, effective compliance management can become a major differentiator in the crowded EHR market. While many view compliance as a necessary hurdle, platforms with robust compliance frameworks not only ensure regulatory adherence but can also enhance their reputations and market positioning. Looking Ahead: The Future of Financial Solutions in EHR The integration of EHRs with financial functionalities is just the beginning. The focus on seamless payment processes will expand into areas such as accounts payable and lend support for small business loans, creating an all-in-one solution for healthcare practices. This comprehensive approach not only supports improved financial management but ultimately benefits patient care by allowing healthcare providers to reinvest in their practices. The Call to Action for SaaS Leaders For healthcare SaaS leaders, adapting to this new paradigm is critical. Forsyth emphasizes the importance of focusing on workflows that alleviate human bottlenecks, such as administrative oversight and patient billing. The essence of a competitive EHR solution lies not just in offerings but in understanding value creation through better financial integration. As the healthcare landscape transforms, practitioners and technology providers must evolve to create a synergistic environment where administrative efficiency meets patient-centered care.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*